Intermediate vancomycin susceptibility in a community-associated MRSA clone

被引:58
作者
Graber, Christopher J. [1 ]
Wong, Margaret K. [1 ]
Carleton, Heather A. [1 ]
Perdreau-Remington, Francoise [1 ]
Haller, Barbara L. [1 ]
Chambers, Henry F. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, San Francisco, CA 94110 USA
关键词
D O I
10.3201/eid1303.060960
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe a case of treatment failure caused by a strain of USA300 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility to vancomycin and reduced susceptibility to claptomycin. The strain was isolated from the bone of a 56-year-old man with lumbar osteomyelitis after a 6-week treatment course of vancomycin for catheter-associated septic thrombophlebitis.
引用
收藏
页码:491 / 493
页数:3
相关论文
共 15 条
[1]   Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates [J].
Boyle-Vavra, S ;
Berke, SK ;
Lee, JC ;
Daum, RS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :272-277
[2]   Community-adapted methicillin-resistant Staphylococcus aureus (MRSA):: Population dynamics of an expanding community reservoir of MRSA [J].
Carleton, HA ;
Diep, BA ;
Charlebois, ED ;
Sensabaugh, GF ;
Perdreau-Remington, F .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (10) :1730-1738
[3]   Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus [J].
Cui, LZ ;
Iwamoto, A ;
Lian, JQ ;
Neoh, HM ;
Maruyama, T ;
Horikawa, Y ;
Hiramatsu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :428-438
[4]   Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus [J].
Diep, BA ;
Carleton, HA ;
Chang, RF ;
Sensabaugh, GF ;
Perdreau-Remington, F .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (11) :1495-1503
[5]   Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus [J].
Diep, BA ;
Gill, SR ;
Chang, RF ;
Phan, TH ;
Chen, JH ;
Davidson, MG ;
Lin, F ;
Lin, J ;
Carleton, HA ;
Mongodin, EF ;
Sensabaugh, GF ;
Perdreau-Remington, F .
LANCET, 2006, 367 (9512) :731-739
[6]   Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area [J].
Equía, JM ;
Liu, C ;
Moore, M ;
Wrone, EM ;
Pont, J ;
Gerberding, JL ;
Chambers, HF .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) :1617-1624
[7]   Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus [J].
Finan, JE ;
Archer, GL ;
Pucci, MJ ;
Climo, MW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) :3070-3075
[8]   Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001 [J].
Fridkin, SK ;
Hageman, J ;
McDougal, LK ;
Mohammed, J ;
Jarvis, WR ;
Perl, TM ;
Tenover, FC .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (04) :429-439
[9]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136
[10]   Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia [J].
Lina, G ;
Piémont, Y ;
Godail-Gamot, F ;
Bes, M ;
Peter, MO ;
Gauduchon, V ;
Vandenesch, F ;
Etienne, J .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1128-1132